These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 27513368)

  • 41. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients.
    Rajagopalan N; Maurer J; Kesten S
    Chest; 1996 Feb; 109(2):405-7. PubMed ID: 8620713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
    Kingah PL; Muma G; Soubani A
    Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
    Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
    J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term clarithromycin therapy in the management of lung transplant recipients.
    Benden C; Boehler A
    Transplantation; 2009 May; 87(10):1538-40. PubMed ID: 19461491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.
    Bergeron A; Godet C; Chevret S; Lorillon G; Peffault de Latour R; de Revel T; Robin M; Ribaud P; Socié G; Tazi A
    Bone Marrow Transplant; 2013 Jun; 48(6):819-24. PubMed ID: 23208317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of laparoscopic Nissen fundoplication after pediatric lung or heart-lung transplantation: should this be the standard?
    Zheng C; Kane TD; Kurland G; Irlano K; Spahr J; Potoka DA; Weardon PD; Morell VO
    Surg Endosc; 2011 Jan; 25(1):249-54. PubMed ID: 20585963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation.
    Yomota M; Yanagawa N; Sakai F; Yamada Y; Sekiya N; Ohashi K; Okamura T
    Medicine (Baltimore); 2019 Jan; 98(1):e13951. PubMed ID: 30608429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
    Hostettler KE; Halter JP; Gerull S; Lardinois D; Savic S; Roth M; Tamm M
    Eur Respir J; 2014 Jan; 43(1):221-32. PubMed ID: 23645405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
    Au BK; Au MA; Chien JW
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation.
    Barisione G; Bacigalupo A; Crimi E; Brusasco V
    Chest; 2011 Mar; 139(3):633-639. PubMed ID: 20724742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
    Gazourian L; Coronata AM; Rogers AJ; Weinhouse GL; Soiffer RJ; Antin JH; Ritz J; Ho VT; Baron RM; Washko GR
    Respir Med; 2013 Feb; 107(2):276-83. PubMed ID: 23195332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
    Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
    J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.
    Yates B; Murphy DM; Forrest IA; Ward C; Rutherford RM; Fisher AJ; Lordan JL; Dark JH; Corris PA
    Am J Respir Crit Care Med; 2005 Sep; 172(6):772-5. PubMed ID: 15976371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yadav H; Torghabeh MH; Hogan WJ; Limper AH
    Respir Care; 2023 Oct; 68(10):1406-1416. PubMed ID: 37253610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Gazourian L; Rogers AJ; Ibanga R; Weinhouse GL; Pinto-Plata V; Ritz J; Soiffer RJ; Antin JH; Washko GR; Baron RM; Ho VT
    Am J Hematol; 2014 Apr; 89(4):404-9. PubMed ID: 24375545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.